DNA binding ligands with excellent antibiotic potency against drug-resistant Gram-positive bacteria

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 18, 2002, Pages 2591-2594

  Bürli, Roland W ^a   Ge, Yigong ^a   White, Sarah ^a   Baird, Eldon E ^a   Touami, Sofia M ^a   Taylor, Matthew ^a   Kaizerman, Jacob A ^a   Moser, Heinz E ^a  

^a GeneSoft Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANTIBIOTIC AGENT; DNA; HETEROCYCLIC COMPOUND;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG DNA BINDING; DRUG POTENCY; DRUG SYNTHESIS; GRAM POSITIVE BACTERIUM; NONHUMAN;

AMIDES; ANTI-BACTERIAL AGENTS; DNA; DRUG RESISTANCE, MICROBIAL; GRAM-POSITIVE BACTERIA; LIGANDS;

POSIBACTERIA;

EID: 0037119692     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00515-2     Document Type: Article

References (25)

1. For example: Chu D.T.W., Plattner J.J., Katz L. J. Med. Chem. 39:1996;3833.
2. Jones R.N., Della-Latta P., Lee L.V., Biedenbach D. J. Diagn. Microbiol. Infect. Dis. 42:2002;137.
3. Harley C.B., Reynolds R.P. Nucleic Acids Res. 15:1987;2343.
4. Collado-Vides J., Magasanik B., Gralla J.D. Microbiol. Rev. 55:1991;371.
5. Lisser S., Margalit H. Nucleic Acids Res. 21:1993;1507.
6. Gross, C. A.; Lonetto, M.; Losick, R. In Transcriptional Regulation; McKnight, S. L.; Yamamoto, K. R., Ed.; Cold Spring Harbor Laboratory: Cold Spring Harbor, 1992; p 129.
7. Kornberg A., Baker T.A. DNA Replication. 2nd Ed. 1992;W. H. Freeman & Co, New York.
8. Hawley D.K., McClure W.R. Nucleic Acids Res. 11:1983;2237.
9. Siebenlist U., Simpson R.B., Gilbert W. Cell. 20:1980;269.
10. Naryshkin N., Revyakin A., Kim Y., Mekler V., Ebright R.H. Cell. 101:2000;601.
11. Jaros-Kaminska B., Malagocka E., Ciesielska E., Gniazdowski M. Studia Biophysica. 86:1981;211.
12. Straney D.C., Crothers D.M. Biochemistry. 26:1987;1987.
13. For distamycin, see: Arcamone F., Penco S., Orezzi P., Nicolella V., Pirelli A. Nature. 203:1964;1064. In our assays, distamycin showed MIC values of 32-128 μg/mL against various Gram-positive strains.
14. Dervan P.B. Bioorg. Med. Chem. 9:2001;2215.
15. Sharma S.K., Reddy B.S.N., Lown J.W. Drugs Future. 26:2001;39.
16. Dyatkina N.B., Roberts C.D., Keicher J.D., Dai Y., Nadherny J.P., Zhang W., Schmitz U., Kongpachith A., Fung K., Novikov A.A., Lou L., Velligan M., Khorlin A.A., Chen M.S. J. Med. Chem. 45:2002;805.
17. Boger L.D., Fink B.E., Hedrick M.P. J. Am. Chem. Soc. 122:2000;6382.
18. Kaberdin R.V., Potkin V.I., Ol'dekop Y.A. Zh. Org. Khim. 26:1990;1560.
19. 1H NMR and mass spectrometry and showed purity of at least 90%. The isolated yields after HPLC purification ranged from 10-30%.
20. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents. Proposed Guideline (M26-P); Approved standard (M11-A3); National Committee for Clinical Laboratory Standards: Wayne, PA, 1987.
21. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 4th Ed; Approved Standard (M7-A4); National Committee for Clinical Laboratory Standards: Wayne, PA, 1997.
22. 32P]-TTP.
23. Brosius D.J., Erfle M., Storella J. J. Biol. Chem. 260:1985;3539.
24. Anker L., Testa B., van de Waterbeemd H., Bornand-Crausaz A., Theodorou A., Jenner P., Marsden C.D. Helv. Chim. Acta. 66:1983;542.
25. Yung D.K., Lo E.K.F., Vohra M.M. J. Pharm. Sci. 61:1972;1953.